United Kingdom· GB-APID-4212611000001109
Vancomycin 500mg powder for solution for infusion vials
A medicinal product containing vancomycin, registered in United Kingdom by A A H Pharmaceuticals Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Vancomycin
- Manufacturer
- A A H Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vancomycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVANCOMYCIN APTAPHARMAApta Medica Internacional d.o.o., Ljubljana
- FinlandNorimkoNRIM Limited
- BelgiumVamysin 500 mgTeva Pharma Belgium
- PolandEdicinSandoz GmbH
- SwedenVancomycin Bioglan 500 mg Pulver till koncentrat till infusionsvätska, lösningBioglan AB
- IrelandVancocin 500 mg powder for concentrate for solution for infusion and powder for oral solutionFlynn Pharma Limited
- SwitzerlandVanco Labatec 500 mg, poudre pour solution à diluer pour perfusionLabatec Pharma SA
- SpainVANCOMICINA MIP 500 MG POLVO PARA SOLUCION PARA PERFUSION EFGMip Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Vancocin, Vancomycin Aptapharma
- Belgium · Vancomycine Fresenius Kabi, Vancomycine Sandoz
- Bulgaria · Vancocin Cp, Ванко-Вм
- Cyprus · Vanco, Vanco Sapiens
- Czechia · Cedepos, Edicin
- Germany · Vanco-Saar, Vancomycin "lederle"
- Denmark · Bactocin, Vancocin
- Estonia · Vancomycin Kabi, Vancosan
- Spain · Vancomicina Mip, Vancomicina Noridem
- Finland · Vancomycin Bioglan, Vancomycin Bioglan 500 Mg Pulver Till Koncentrat Till Infusionsvätska, Lösning
- France · Vancomycine Hikma, Vancomycine Kabi
- Greece · Lyovanco, Vancomycin Noridem
- Croatia · Edicin, Vancomicin Viatris
- Hungary · Vancocin, Vancomycin Aptapharma
- Ireland · Vancocin, Vancocin Matrigel
- Iceland · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Italy · Levovanox, Maxivanil
- Lithuania · Vancomycin Ibe, Vancomycin Kabi
- Luxembourg · Vancomycin Enterocaps, Vancomycine
- Latvia · Vancomycin Kabi, Vancosan
- Malta · Cedepos, Vancomycin Aptapharma
- Netherlands · Vancocin Cp, Vancomycine Fresenius Kabi
- Norway · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Poland · Edicin, Vancomicina Reig Jofre
- Portugal · Vancomicina Azevedos, Vancomicina Generis
- Romania · Cedepos, Vancomicină Aptapharma
- Sweden · Vancocin, Vancomycin Bioglan
- Slovenia · Edicin, Vancomycin Viatris
- Slovakia · Cedepos, Edicin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac972952-beb0-4e0d-9434-073a91e2cb49 GET /v1/drugs/ac972952-beb0-4e0d-9434-073a91e2cb49?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4212611000001109",
"desc": "Vancomycin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd)",
"form": "Powder for solution for infusion",
"vpid": "41956611000001106",
"source": "dmd",
"vtm_id": "777914002",
"strength": "500 mg",
"substance": "Vancomycin",
"ingredient": "Vancomycin hydrochloride",
"supplier_code": "3144701000001104"
}See everything about vancomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.